Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma

ClinicalTrials.gov ID: NCT03656536

Public ClinicalTrials.gov record NCT03656536. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-Label, Randomized, Active-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Gemcitabine Plus Cisplatin Chemotherapy in First-Line Treatment of Participants With Unresectable or Metastatic Cholangiocarcinoma With FGFR2 Rearrangement (FIGHT-302)

Study identification

NCT ID
NCT03656536
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
167 participants

Conditions and interventions

Interventions

  • Pemigatinib Drug
  • Gemcitabine Drug
  • Cisplatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2, 2019
Primary completion
Jul 6, 2025
Completion
Jul 6, 2025
Last update posted
Aug 23, 2025

2019 – 2025

United States locations

U.S. sites
36
U.S. states
26
U.S. cities
32
Facility City State ZIP Site status
Mayo Clinic Arizona Phoenix Arizona 85054
Marin Cancer Care Greenbrae California 94904
UC Irvine Medical Center Orange California 92868-3201
Georgetown University-Lombardi Comprehensive Cancer Center Washington D.C. District of Columbia 20007
Mayo Clinic-Florida Jacksonville Florida 32224
Mount Sinai Medical Center Comprehensive Cancer Center Miami Beach Florida 33140
Winship Cancer Institute of Emory University Atlanta Georgia 30322
University of Chicago Medical Center Chicago Illinois 60637-1447
Parkview Research Center Fort Wayne Indiana 46845
University of Iowa Hospital and Clinics Iowa City Iowa 52242
The University of Kansas Cancer Center Westwood Kansas 66205
Ochsner Clinic Foundation Ocf Ochsner Cancer Institute Oci New Orleans Louisiana 70121
Johns Hopkins Oncology Center Baltimore Maryland 21287
Boston Medical Center Boston Massachusetts 02118
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Barbara Ann Karmanos Cancer Hospital Detroit Michigan 48201
Henry Ford Hospital Detroit Michigan 48202
Karmanos Cancer Institute Farmington Hills Michigan 48334
Mayo Clinic Rochester Minnesota 55905
Comprehensive Cancer Centers of Nevada-Twain Las Vegas Nevada 89169
Summit Medical Group Florham Park New Jersey 07932
Icahn School of Medicine At Mount Sinai New York New York 10029
White Plains Hospital White Plains New York 10601
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Cleveland Clinic Foundation Cleveland Ohio 44195
Providence Portland Med. Ctr Portland Oregon 97213
Oregon Health & Science University Portland Oregon 97239
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Greenville Hospital System University Medical Center Institute For Translational Oncology Research Greenville South Carolina 29605
Baylor Scott and White Research Institute Dallas Texas 75246
Houston Methodist Research Institute Houston Texas 77030
Riverside Regional Medical Center Newport News Virginia 23601
Virginia Commonwealth University Richmond Virginia 23229
Virginia Mason Medical Center Seattle Washington 98101
West Virginia University Cancer Institute Morgantown West Virginia 26506
Aurora Research Institute Wauwatosa Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 179 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03656536, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 23, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03656536 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →